BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33116738)

  • 1. A Split-Face Study Assessing the Clinical Benefit, Tolerability and Subject Satisfaction of a Dermocosmetic in Subjects with Rosacea Associated with Erythema and Sensitive Skin.
    Berardesca E; Bonfigli A; Cribier B; Flament F; Vicic M; Kerob D; Tan J
    Clin Cosmet Investig Dermatol; 2020; 13():751-758. PubMed ID: 33116738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized, Controlled Clinical Trial of a Dermocosmetic Containing Vichy Volcanic Mineralizing Water and Probiotic Fractions in Subjects with Rosacea Associated with Erythema and Sensitive Skin and Wearing Protective Masks.
    Berardesca E; Bonfigli A; Cartigliani C; Kerob D; Tan J
    Clin Cosmet Investig Dermatol; 2023; 16():71-77. PubMed ID: 36660190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the efficacy and tolerance of a cosmetic mask containing 89% of vichy volcanic mineralizing water and hyaluronic acid after facial laser procedures.
    Torreao P; Phua E; Clark R; Fernandes E; Pontes T; Fonseca AP; Singh N; Seesurn B; Nielsen M; Valois A; Kerob D
    J Cosmet Dermatol; 2021 Sep; 20(9):2860-2866. PubMed ID: 33538111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 89% Vichy mineralizing water with hyaluronic acid is a well-tolerated adjunct treatment that helps restore skin barrier function in dry skin-related inflammatory dermatoses and post-procedure skin care: A Canadian study.
    Hong CH; Schachter J; Sutton AB; Salsberg JM; Li MK; Humphrey SD; Dayeh NR
    J Cosmet Dermatol; 2021 Jul; 20(7):2148-2155. PubMed ID: 33786979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vichy mineralizing water with hyaluronic acid is effective and well tolerated as an adjunct to the management of various dermatoses and after esthetic procedures.
    Tan J; Spada J; Orlandi C; Kerscher M; Anfilova M; Abdulla S; Floriánová A; Preisz K; Altmayer A; Delva C; Kerob D; Goldobina M; Arenbergerová M; Tuz S; Araviiskaia E
    J Cosmet Dermatol; 2020 Mar; 19(3):682-688. PubMed ID: 31793738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised, split-face study of a dermocosmetic cream containing Sphingobioma xenophaga extract and Neurosensine
    Berardesca E; Cartigliani C; Nioré M; Bonfigli A; Canchy L; Kerob D; Tan J
    Skin Res Technol; 2024 Jun; 30(6):e13735. PubMed ID: 38899754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of the Dermocosmetic Mineral 89 Probiotic Fractions Adjunct to Topical Retinoids for Anti-Aging Benefits.
    Valpaços C; Leclerc-Mercier S; Lopes L; Svoboda D; Miranda D; Correia P; Junior J; Fernandes E; Francois-Newton V; Mandary MB; Gueniche A; Tan J; Kerob D
    Clin Cosmet Investig Dermatol; 2023; 16():375-385. PubMed ID: 36798538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin treatment in rosacea: How novel smartphone technology can support monitoring rosacea-associated signs and symptoms.
    Schaller M; Riel S; Bashur R; Kurup N; Schnidar H; Fehrenbacher B
    Dermatol Ther; 2022 Nov; 35(11):e15869. PubMed ID: 36177738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a novel very high sun-protection-factor moisturizer in adults with rosacea-prone sensitive skin.
    Grivet-Seyve M; Santoro F; Lachmann N
    Clin Cosmet Investig Dermatol; 2017; 10():211-219. PubMed ID: 28652793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of low molecular weight hyaluronic acid sodium salt 0.2% cream in rosacea.
    Schlesinger TE; Powell CR
    J Drugs Dermatol; 2013 Jun; 12(6):664-7. PubMed ID: 23839183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety results of micellar water, cream and serum for rosacea in comparison to a control group.
    Guertler A; Jøntvedt NM; Clanner-Engelshofen BM; Cappello C; Sager A; Reinholz M
    J Cosmet Dermatol; 2020 Oct; 19(10):2627-2633. PubMed ID: 32623833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vichy volcanic mineralizing water has unique properties to strengthen the skin barrier and skin defenses against exposome aggressions.
    Rasmont V; Valois A; Gueniche A; Sore G; Kerob D; Nielsen M; Berardesca E
    J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 2():5-15. PubMed ID: 34979589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Skin Care Products as Adjunctive to Prescription Therapy in Moderate to Severe Rosacea.
    Draelos ZD; Gunt H; Levy SB
    J Drugs Dermatol; 2019 Feb; 18(2):141-146. PubMed ID: 30794364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel moisturizer with high sun protection factor improves cutaneous barrier function and the visible appearance of rosacea-prone skin.
    Baldwin H; Santoro F; Lachmann N; Teissedre S
    J Cosmet Dermatol; 2019 Dec; 18(6):1686-1692. PubMed ID: 30803131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Dermocosmetic Significantly Reduces the Frequency and Intensity of Facial Skin Intolerability and Sensitivity in Subjects with Skin Intolerant to Skin Care Products and Sensitive Skin.
    Kerob D; Czermanska A; Karamon EM; Moga A; Lecerf G; Nioré M; Le Dantec G; Le Floc'h C; Tan J
    Clin Cosmet Investig Dermatol; 2023; 16():1787-1794. PubMed ID: 37456802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open-label study assessing the efficacy and tolerability of topical skin care and sun protection alone and in combination with intense pulsed light therapy.
    Deaver Peterson J; Katz TM
    J Cosmet Dermatol; 2019 Dec; 18(6):1758-1764. PubMed ID: 31017734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of permethrin 2.5% with tea tree oil gel on rosacea treatment: A double-blind, controlled clinical trial.
    Ebneyamin E; Mansouri P; Rajabi M; Qomi M; Asgharian R; Azizian Z
    J Cosmet Dermatol; 2020 Jun; 19(6):1426-1431. PubMed ID: 31613050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea.
    Laquieze S; Czernielewski J; Baltas E
    J Dermatolog Treat; 2007; 18(3):158-62. PubMed ID: 17538804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
    Karabulut AA; Izol Serel B; Eksioglu HM
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical PRK 124 (0.125%) lotion for improving the signs and symptoms of rosacea.
    Ortiz A; Elkeeb L; Truitt A; Hindiyeh R; Aquino L; Tran M; Weinstein G
    J Drugs Dermatol; 2009 May; 8(5):459-62. PubMed ID: 19537369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.